These results validated the prediction efficiency of our novel constructed cell infiltration classifier based on the expression of the 3 hub genes, confirming that CRC patients with upregulated BMP5 and downregulated HOXC6/8 were related with lower pathologic stages and better prognosis. The gene discussed is HOXC6; the disease is colorectal carcinoma.